An unexpected N‐substituted oxindole: 5‐methyl‐1‐(3,3,5‐trimethyl‐2‐p‐tolyl‐1,2‐oxazolidin‐5‐yl)‐1H‐indol‐3(2H)‐one

By  

Acta Crystallographica Section E, Vol. 63, Iss. 2, 2007-02 ,pp. : o875-o876

John Wiley & Sons Inc

Access to resources Recommend Favorite

N‐[(3‐Methyl‐1‐phenyl­sulfonyl‐1H‐indol‐2‐yl)meth­yl]‐1,1‐dioxo‐1‐benzo[d]isothia­zol‐3(2H)‐one

By  

Acta Crystallographica Section E, Vol. 63, Iss. 4, 2007-04 ,pp. : o2026-o2028

John Wiley & Sons Inc

Access to resources Recommend Favorite

4‐(1H‐Indol‐3‐ylmethyl­eneamino)‐1,5‐dimethyl‐2‐phenyl‐1H‐pyrazol‐3(2H)‐one

By  

Acta Crystallographica Section E, Vol. 63, Iss. 2, 2007-02 ,pp. : o418-o419

John Wiley & Sons Inc

Access to resources Recommend Favorite

Novel N-Substituted 2-(2-(Adamantan-1-yl)-1H-Indol-3-yl)-2-Oxoacetamide Derivatives: Synthesis and Biological Evaluation

By Hu Hong-Yu   Yu Xu-Dong   Wang Fei   Lin Chun-Rong   Zeng Jin-Zhang   Qiu Ying-Kun   Fang Mei-Juan   Wu Zhen  

Molecules, Vol. 21, Iss. 5, 2016-05 ,pp. : 530-530

MDPI

Access to resources Recommend Favorite

1‐(Benzylideneacetyl)‐2‐phenyl‐1,2,3,5,10,10a‐hexahydro‐1H‐pyrrolo[1,2‐b]isoquinoline‐3‐spiro‐3′(2′H)‐1H‐indol‐3′‐one

By  

Acta Crystallographica Section E, Vol. 63, Iss. 8, 2007-08 ,pp. : o3490-o3490

John Wiley & Sons Inc

Access to resources Recommend Favorite